Abbott/Sandoz’ Hytrin Agreement Violates Antitrust Law, Judge Says
This article was originally published in The Pink Sheet Daily
A provision under which Sandoz (formerly Geneva) agreed not to market generic terazosin until an appellate ruling in underlying patent litigation “exceeded the scope” of the potential exclusionary effect of Abbott’s patent, court says. The ruling marks the second time the judge has found the agreement to violate antitrust law.
You may also be interested in...
The two cases created an apparent disagreement among the federal appellate circuits on the legality of “reverse payments” from a brand company to delay a generic’s entry.
US FDA received 110 designation requests in July, a high mark that reflects the 60 days needed to review such requests ahead of the 30 September statutory expiration; agency is allowing email submission of RPD and orphan drug designation requests during the COVID-19 pandemic and expects to roll out an online portal for orphan designation requests later this year.
Most vaccines will be distributed centrally by McKesson, but those with ultra-cold storage requirements will be shipped directly from the manufacturer to the vaccination site. Data exchange system will enable public and private databases to talk to each other and help ensure individuals receive timely revaccination with a second dose of the same vaccine regardless of location.